Pesquisas alternativas:
evolves. » evolved. (Expandir a Pesquisa), evolve. (Expandir a Pesquisa)
revolvesdsds. » revolveddsds. (Expandir a Pesquisa), revolvedsds. (Expandir a Pesquisa), resolvesdsds. (Expandir a Pesquisa), evolveddsds. (Expandir a Pesquisa), evolvedsds. (Expandir a Pesquisa)
revolves. » revolved. (Expandir a Pesquisa), revolve. (Expandir a Pesquisa), resolves. (Expandir a Pesquisa), evolved. (Expandir a Pesquisa), evolve. (Expandir a Pesquisa)
evolves. » evolved. (Expandir a Pesquisa), evolve. (Expandir a Pesquisa)
revolvesdsds. » revolveddsds. (Expandir a Pesquisa), revolvedsds. (Expandir a Pesquisa), resolvesdsds. (Expandir a Pesquisa), evolveddsds. (Expandir a Pesquisa), evolvedsds. (Expandir a Pesquisa)
revolves. » revolved. (Expandir a Pesquisa), revolve. (Expandir a Pesquisa), resolves. (Expandir a Pesquisa), evolved. (Expandir a Pesquisa), evolve. (Expandir a Pesquisa)
-
421
Analysis of GO terms enriched or depleted in EV proteomes compared with trophozoite proteomes.
Publicado em 2025Assuntos: -
422
GO term analysis of cellular components enriched or depleted in EV compared with trophozoite proteomes.
Publicado em 2025Assuntos: -
423
-
424
Distribution of SCCmec types according to antibiotic resistance phenotypes for MRSA.
Publicado em 2022Assuntos: -
425
-
426
-
427
Cellular uptake of <i>E. histolytica</i> EVs and activation of primary monocytes.
Publicado em 2025Assuntos: -
428
-
429
Comparison of the <i>E. histolytica</i> vesicle and trophozoite proteomes.
Publicado em 2025Assuntos: -
430
-
431
-
432
-
433
Secondary antibody controls for immunogold labeling of <i>Eh</i>A1 and <i>Eh</i>B2 EVs.
Publicado em 2025Assuntos: -
434
-
435
Quantification of cytokine and myeloperoxidase release upon EV stimulation.
Publicado em 2025Assuntos: -
436
-
437
Flow cytometry analysis of marker expression on EV-stimulated monocytes.
Publicado em 2025Assuntos: -
438
Target prediction of novel <i>E. histolytica</i> miRNAs in the human and <i>E. histolytica</i> genome.
Publicado em 2025Assuntos: -
439
-
440